Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT00391066 · TERMINATED
Trial details
- NCT number
- NCT00391066
- Sponsor
- Biogen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2010-07-01
- Enrollment
- 627
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.